Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily Oxycodone HCl XL versus twice-daily Oxygesic in chronic cancer pain
2010-020402-15Phase 3Completed
- Sponsor
- Develco Pharma
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone in cancer pain (2 arms), sponsored by Develco Pharma. Primary endpoint: Overall current pain intensity. Started Jul 2010; status: completed.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2010-020402-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020402-15.